TCIM
FBIO icon

TIAA CREF Investment Management’s Fortress Biotech FBIO Stock Holding History

TIAA CREF Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,975
Closed -$95K – 3019
2018
Q3 		$95K Sell
3,975
-992
-20% -$31.7K ﹤0.01% 3037
2018
Q2 		$222K Sell
4,967
-1,329
-21% -$74.8K ﹤0.01% 3018
2018
Q1 		$430K Hold
6,296
– – ﹤0.01% 2805
2017
Q4 		$377K Sell
6,296
-199
-3% -$11.7K ﹤0.01% 2889
2017
Q3 		$431K Hold
6,495
– – ﹤0.01% 2893
2017
Q2 		$463K Sell
6,495
-652
-9% -$38.5K ﹤0.01% 2899
2017
Q1 		$397K Sell
7,147
-241
-3% -$10.8K ﹤0.01% 2871
2016
Q4 		$299K Sell
7,388
-160
-2% -$5.98K ﹤0.01% 2979
2016
Q3 		$336 Hold
7,548
– – ﹤0.01% 2974
2016
Q2 		$305K Buy
+7,548
New +$351K ﹤0.01% 3025
2014
Q2 		– Sell
-6,642
Closed -$197K – 3131
2014
Q1 		$197K Hold
6,642
– – ﹤0.01% 3077
2013
Q4 		$262K Sell
6,642
-1,731
-21% -$66.8K ﹤0.01% 3067
2013
Q3 		$882K Buy
8,373
+235
+3% +$28.8K ﹤0.01% 2685
2013
Q2 		$1.05M Buy
+8,138
New +$1.2M ﹤0.01% 2553

Other funds holding FBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.84B AUM 31.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TIAA CREF Investment Management's FBIO Position: Q4 2018 in Review

TIAA CREF Investment Management sold out of Fortress Biotech (FBIO) in Q4 2018, closing a stake of 3,975 shares — an estimated $95K sold.

TIAA CREF Investment Management first reported a position in FBIO in Q2 2013 and held it in 14 quarters. The position peaked at $1.05M in Q2 2013. 61 funds tracked by Wall St. Rank hold FBIO as of Q4 2018.

  • TIAA CREF Investment Management reported no remaining Fortress Biotech position as of Q4 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 3,975 Fortress Biotech shares in Q4 2018, an estimated $95K.
  • TIAA CREF Investment Management first reported a position in Fortress Biotech in Q2 2013 and held it in 14 quarters.
  • TIAA CREF Investment Management's Fortress Biotech position peaked at $1.05M in Q2 2013.
  • 61 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2018.

Based on TIAA CREF Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.